leadf
logo-loader
viewOpyl Ltd

ShareRoot Ltd bags A$1 million to fund global growth strategy

The company's user base has nearly doubled quarter-on-quarter.

AustralianHundredDollar757x468_595c640e2e8e7.jpg
ShareRoot is focused on developing new features

ShareRoot Ltd (ASX:SRO) has successfully completed an oversubscribed share placement to professional and sophisticated investors to raise A$1 million at A$0.006 per share.

The placement was strongly oversubscribed and ShareRoot elected to take some additional capital above the $700,000 it was seeking to raise, but did not take all of the significant demand received.

This placement strengthens ShareRoot’s financial position heading into the new financial year, with funds to be used to fund its global growth strategy and ongoing operations.

ShareRoot’s user-generated content (UGC) platform allows customers to search for user-generated media content across a range of social media platforms and request permission to use the content.

The customers can then effectively utilise these materials as part of their marketing campaigns.

ShareRoot’s cloud-based platform helps customers avoid the legal disputes and intellectual property headaches that can emerge from sharing user-generated content as part of their marketing efforts.

The company will now focus on the development of new protectable features for its UGC marketing platform.

This feature is planned to be rolled out progressively through 2017 and is expected to contribute to sales and revenue growth by providing customers with additional value and functionality.

ShareRoot’s user base has nearly doubled quarter-on-quarter to 180,000 users at the end of June, up from just under 100,000 active users at the end of March 2017.

Quick facts: Opyl Ltd

Price: 0.14 AUD

ASX:OPL
Market: ASX
Market Cap: $5.16 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Opyl Ltd named herein, including the promotion by the Company of Opyl Ltd in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Opyl Ltd CEO says successful COVID-19 data trial is validation of its platform

Opyl Ltd's (ASX:OPL) Michelle Gallaher updates Proactive's Andrew Scott on developments with their clinical predictor and clinical trials recruitment platforms. The company's developed software that uses artificial intelligence (AI) to make a probability of success prediction on the likelihood...

5 days, 23 hours ago

2 min read